German University in Cairo
🇩🇪Germany
Clinical Trials
8
Active:1
Completed:3
Trial Phases
3 Phases
Phase 1:1
Phase 2:5
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (71.4%)Phase 1
1 (14.3%)Phase 3
1 (14.3%)The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study
Phase 2
Completed
- Conditions
- Multiple Sclerosis (MS) - Relapsing-remitting
- Interventions
- Other: Usual CareDrug: Metformin (Cidophage®)
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 30
- Registration Number
- NCT06812585
- Locations
- 🇪🇬
Nasser Institute for Research and Treatment, Cairo, Egypt
L-carnitine Supplementation in Rheumatoid Arthritis Patients
Phase 2
Recruiting
- Conditions
- Rheumatoid Arthritis (RA)
- Interventions
- Drug: Disease-modifying anti-rheumatic drugs
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 60
- Registration Number
- NCT06753565
- Locations
- 🇪🇬
Demerdash hospital, Cairo, Demerdash, Egypt
Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 70
- Registration Number
- NCT06458686
Clinical Evaluation of the Effect of Metformin in Sepsis
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 110
- Registration Number
- NCT05979038
- Locations
- 🇪🇬
Al Demerdash University Hospital, Cairo, Egypt
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
Active, not recruiting
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- German University in Cairo
- Target Recruit Count
- 138
- Registration Number
- NCT05735067
- Locations
- 🇪🇬
Nasser Institute for Research and Treatment, Cairo, Egypt
- Prev
- 1
- 2
- Next
News
No news found